A nurse is caring for a client that has type 2 diabetes.
Which of the following medications is used to treat type 2 diabetes and has an interaction with iodine-containing contrast dye?

Choice A rationale

Intravenous, intramuscular, and intradermal routes bypass the first-pass effect as they do not pass through the liver first.

Choice B rationale

Enteric-coated tablets and capsules are designed to bypass the stomach and dissolve in the intestines, reducing the first-pass effect.

Choice C rationale

The first-pass effect involves the liver metabolizing and inactivating a portion of the medication on its first pass through the liver.

Choice D rationale

Enteral medications, which pass through the digestive system, may require higher doses due to the first-pass effect where the liver metabolizes the medication before it reaches systemic circulation. .

Choice A rationale

Rotating injection sites helps prevent lipohypertrophy, which is the thickening of subcutaneous tissue due to repeated insulin injections at the same site.

Choice B rationale

Performing injections at the same location every time increases the risk of lipohypertrophy, leading to poor insulin absorption and erratic glucose control.

Choice C rationale

Administering an additional dose of insulin as needed does not address the issue of lipohypertrophy and can lead to hypoglycemia if not carefully monitored.

Choice D rationale

Insulin is a peptide hormone that must be injected. Taking it orally is ineffective as it would be broken down in the digestive system.